Skip to main content

Tweets

NICE Guidelines on Gout Diagnosis and Management NICE (UK) has systematically reviewed current medical evidence and delivered a set of recommendations with consideration of cost effectiveness. https://t.co/ckDrfVAynN https://t.co/jzBviwpxGL
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
Risk of TNFi-related psoriasis in 5088 TNFi Rx children w/ IBD, JIA, or CNO. Compared to non-TNFi exposed, kids on TNFi had an increased PSO risk w/ ADA (IRR 2.70; 1.53-4.75), infliximab (2.34) or etanercept (2.21) & not incr w/ DMARD use https://t.co/MyjLfeoChq https://t.co/A3JJUA1AaM
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
Cranial nerves exam (unknown source) #BJHM #Neurotwitter #Medtwitter #MedEd #medstudents https://t.co/NnUx6tGERn
Brown Journal of Hospital Medicine @BrownJHM ( View Tweet )
3 years 10 months ago
New data at today's CDC/ACIP meeting on vaccine effectiveness vs BA.5 wave hospitalizations, all adults https://t.co/64b9g7HW1h Less protection for both 3rd and 4th dose vaccines compared with the prior wave (BA.2, BA.2.12) https://t.co/JTichjw2I3
Eric Topol @EricTopol ( View Tweet )
3 years 10 months ago
Calling All Rheumatology Fellows! Join the ACR Fellows-in-Training Subcommittee https://t.co/FSyMjVieAD

Dr. John Cush @RheumNow ( View Tweet )

3 years 10 months ago
Gout: diagnosis and management—summary of NICE guidance https://t.co/zOdPzGtqg7 https://t.co/N7CJ23vLND
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
OPTION-DM study of 140 diabetic neuropathy pts Rx for 16 weeks w/ one agent (& if no response) an add-on agent. At wk 16, all 3 regimens lowered nerve pain score from 6.6 to 3.3 w/ no difference between Elavil+Lyrica, Lyrica+Elavil, o Cymbalta+Lyrica) https://t.co/rijJyq1DYL https://t.co/NwHF6xuF0j
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
Have you registered for RheumNow yet? With registration you'll be able to sign up for our daily email, as well as our topic specific emails. RheumNow is where rheumatologists come to learn. https://t.co/NuN8JL37tk https://t.co/urJGorSzxo
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
Prevalent Sleep Problems in Rheumatoid Arthritis Data from Data FORWARD (The National Databank for Rheumatic Diseases) reveals that nearly two-thirds of rheumatoid arthritis (RA) patients have self-reported sleep problems. https://t.co/WHv3BBeI8T https://t.co/awSy2VqBIn
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
Disease Activity Scoring in AOSD AOSD or sJIA can have dramatic symptom severity, making it easy to gauge disease activity and response to therapy, especially at the outset. However, a validated measure of disease activity has not been agreed upon. https://t.co/oD6uDD6W8m https://t.co/KxNJeJ31h8
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
ANA Increasing? Part of the NHANES survey, ANA (IIF on HEp-2 cells) was performed on 13,519 in 3 periods: 1988-1991, 1999-2004, and 2011-2012. ANA+ was 11% 1988-1991 11.4% 1999-2004 16.1% 2011-2012 (P <0.0001) Meaning ~22.3, ~26.6, &~41.5 mil had +ANAs https://t.co/vWYJci3uDV https://t.co/SEIbrYRoRJ
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
SURPRISED? Psoriasis pts have a known increased risk of CV disease. But did you know several papers & metanalyses show increased risk of abdominal aortic aneurysm in PSO (HR 1.30), worse w/ dz activity; lost w/ age, female, DM? https://t.co/UssLZsBJle https://t.co/ESGK8fjjJk https://t.co/CBBYZRCjCA
Dr. John Cush @RheumNow ( View Tweet )
3 years 10 months ago
×